Show results for
Refine by
Detection Of Biomarkers Suppliers In Europe
7 companies found
based inNeuchâtel, SWITZERLAND
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention ...
based inValencia, SPAIN
Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range ...
based inBerlin, GERMANY
Good diagnostic products require high-quality human biomaterials (serums, standards, control samples, purified proteins, and antibodies). Out of this need, we founded ourselves in 1997 as a spin-off of the research department of B.R.A.H.M.S. AG. ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inLiège, BELGIUM
ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for the screening of rare, genetic, chronic or infectious metabolic diseases in human ...
based inBillerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The ...